Brainstorm Cell Therapeutics's total assets for Q4 2025 were $715.00K, a decrease of -48.19% from the previous quarter. BCLI total liabilities were $11.01M for the fiscal quarter, a 21.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.